BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8481666)

  • 1. The role of interferon in the therapy of low grade lymphoma.
    McLaughlin P
    Leuk Lymphoma; 1993; 10 Suppl():17-20. PubMed ID: 8481666
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
    Steis RG; Foon KA; Longo DL
    Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma].
    Klee M; Illiger HJ
    Strahlenther Onkol; 2001 Sep; 177(9):494-5. PubMed ID: 11591024
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic therapies for low-grade lymphomas.
    Parkinson DR; Sznol M; Cheson BD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):111-7. PubMed ID: 8211201
    [No Abstract]   [Full Text] [Related]  

  • 5. Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group.
    Tirelli U
    Leukemia; 1991; 5 Suppl 1():105-6. PubMed ID: 1890859
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of low malignancy non-Hodgkin lymphomas with recombinant interferon. Current status].
    Neubauer A; Herrmann R
    Med Klin (Munich); 1989 Jul; 84(7):355-8. PubMed ID: 2677632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)].
    Chisesi T
    Haematologica; 1990; 75 Suppl 4():72-7. PubMed ID: 2074057
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials referral resource. Non-Hodgkin's lymphoma.
    Cheson BD
    Oncology (Williston Park); 1989 Oct; 3(10):37-40, 45-50. PubMed ID: 2640585
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
    Smruti BK; Nair R; Gopal R
    J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
    Chisesi T; Capnist G; Vespignani M; Dini E
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691
    [No Abstract]   [Full Text] [Related]  

  • 11. Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma.
    Harrington WJ; Cabral L; Cai JP; Chan-A-Sue S; Wood C
    Lancet; 1996 Sep; 348(9030):833. PubMed ID: 8814017
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
    Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
    J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
    Enschede SH; Porter C; Venugopal P; Gregory SA
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):229-33. PubMed ID: 16163187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon and corticosteroids as initial treatment in small cleaved-cell lymphoma.
    Flecknoe-Brown S
    Leuk Lymphoma; 1995 Jul; 18(3-4):353-6. PubMed ID: 8535205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
    Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
    Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
    Andersen JW; Smalley RV
    N Engl J Med; 1993 Dec; 329(24):1821-2. PubMed ID: 8232506
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of low-grade non-Hodgkin lymphoma in 1996].
    Mandigers CM; Raemaekers JM; Bogman MJ; de Pauw BE
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1587-91. PubMed ID: 8768811
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
    J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of lymphoma of a higher stage of malignancy treated with cytostatics and interferon].
    Cieślińska A
    Pol Tyg Lek; 1988 Jul; 43(28):917-8. PubMed ID: 3247263
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of interferon-alfa in NHL: still controversial?
    Haase-Statz S; Smalley RV
    Oncology (Williston Park); 1999 Aug; 13(8):1147-59; discussion 1159-60, 1163. PubMed ID: 10499247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.